Sophion Bioscience Collaborates with Merck
News Dec 21, 2005
Sophion Bioscience, Inc. and Sophion Bioscience A/S (Ballerup, Denmark) have announced collaboration with Merck & Co., Inc. to complete the QPatch HT, a 48-channel automated, gigaseal patch clamp system.
QPatch HT is a second-generation instrument based on the QPatch 16, a 16-channel automated patch clamp system marketed by Sophion and in use at pharmaceutical and biotech companies around the world for hERG testing, ion channel screening and drug discovery programs.
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018